Psyence Biomedical Ltd.
13F holders, Q2 2025 (June 30)1holders −7
1new positions
9sold out
$1.68avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Psyence Biomedical Ltd. in their 13F filings, down 7 from Q1 2025. 1 opened new positions and 9 sold out. The largest holder was Parallel Advisors, LLC ($462K).
- Company
- Psyence Biomedical Ltd.
- CUSIP
- 74449F209
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $462K |
| Exits | 9 | $273K |
All 13F filers, Q1 2025 → Q2 2025: 275,000 shares bought and 455,006 shares sold, net −180,006 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Parallel Advisors, LLC | 0.01% | New | 275,000 | $462K |
"% of holder's portfolio" is PSYENCE BIOMEDICAL LTD's weight in each manager's 13F, not the share of Psyence Biomedical Ltd. the manager owns.